{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:40:11Z","timestamp":1790178011767,"version":"4.1.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,6,3]],"date-time":"2018-06-03T00:00:00Z","timestamp":1527984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002848","name":"Comisi\u00f3n Nacional de Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["CONICYT-PFB 12\/2007"],"award-info":[{"award-number":["CONICYT-PFB 12\/2007"]}],"id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002848","name":"Comisi\u00f3n Nacional de Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["AFB 170005"],"award-info":[{"award-number":["AFB 170005"]}],"id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1160724"],"award-info":[{"award-number":["1160724"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["11170212"],"award-info":[{"award-number":["11170212"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s12035-018-1148-z","type":"journal-article","created":{"date-parts":[[2018,6,3]],"date-time":"2018-06-03T05:59:14Z","timestamp":1528005554000},"page":"1044-1055","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Revisiting the Paraquat-Induced Sporadic Parkinson\u2019s Disease-Like Model"],"prefix":"10.1007","volume":"56","author":[{"given":"Sussy","family":"Bast\u00edas-Candia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Zolezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3118-9726","authenticated-orcid":false,"given":"Nibaldo C.","family":"Inestrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,3]]},"reference":[{"key":"1148_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/00005053-197803000-00010","volume":"166","author":"KL Davis","year":"1978","unstructured":"Davis KL, Yesavage JA, Berger PA (1978) Single case study. Possible organophosphate-induced parkinsonism. J Nerv Ment Dis 166:222\u2013225","journal-title":"J Nerv Ment Dis"},{"key":"1148_CR2","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/S0140-6736(06)69665-7","volume":"368","author":"P Grandjean","year":"2006","unstructured":"Grandjean P, Landrigan PJ (2006) Developmental neurotoxicity of industrial chemicals. Lancet 368:2167\u20132178. https:\/\/doi.org\/10.1016\/S0140-6736(06)69665-7","journal-title":"Lancet"},{"key":"1148_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1600-0404.1986.tb03529.x","volume":"74","author":"SM Aquilonius","year":"1986","unstructured":"Aquilonius SM, Hartvig P (1986) A Swedish county with unexpectedly high utilization of anti-parkinsonian drugs. Acta Neurol Scand 74:379\u2013382","journal-title":"Acta Neurol Scand"},{"key":"1148_CR4","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1212\/WNL.46.5.1275","volume":"46","author":"A Seidler","year":"1996","unstructured":"Seidler A, Hellenbrand W, Robra BP, Vieregge P, Nischan P, Joerg J, Oertel WH, Ulm G et al (1996) Possible environmental, occupational, and other etiologic factors for Parkinson\u2019s disease: a case-control study in Germany. Neurology 46:1275\u20131284","journal-title":"Neurology"},{"key":"1148_CR5","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1212\/WNL.50.5.1346","volume":"50","author":"JM Gorell","year":"1998","unstructured":"Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ (1998) The risk of Parkinson\u2019s disease with exposure to pesticides, farming, well water, and rural living. Neurology 50:1346\u20131350","journal-title":"Neurology"},{"key":"1148_CR6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0161-813X(02)00099-2","volume":"23","author":"DA Monte Di","year":"2002","unstructured":"Di Monte DA, Lavasani M, Manning-Bog AB (2002) Environmental factors in Parkinson\u2019s disease. Neurotoxicology 23:487\u2013502","journal-title":"Neurotoxicology"},{"key":"1148_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/096032719401300206","volume":"13","author":"P Casey","year":"1994","unstructured":"Casey P, Vale JA (1994) Deaths from pesticide poisoning in England and Wales: 1945-1989. Hum Exp Toxicol 13:95\u2013101. https:\/\/doi.org\/10.1177\/096032719401300206","journal-title":"Hum Exp Toxicol"},{"key":"1148_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.nbd.2005.03.018","volume":"20","author":"F Cicchetti","year":"2005","unstructured":"Cicchetti F, Lapointe N, Roberge-Tremblay A, Saint-Pierre M, Jimenez L, Ficke BW, Gross RE (2005) Systemic exposure to paraquat and maneb models early Parkinson\u2019s disease in young adult rats. Neurobiol Dis 20:360\u2013371. https:\/\/doi.org\/10.1016\/j.nbd.2005.03.018","journal-title":"Neurobiol Dis"},{"key":"1148_CR9","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1016\/j.parkreldis.2008.04.012","volume":"14","author":"GE Meredith","year":"2008","unstructured":"Meredith GE, Totterdell S, Potashkin JA, Surmeier DJ (2008) Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol. Parkinsonism Relat Disord 14:S112\u2013S115. https:\/\/doi.org\/10.1016\/j.parkreldis.2008.04.012","journal-title":"Parkinsonism Relat Disord"},{"key":"1148_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0006-8993(00)02496-3","volume":"873","author":"M Thiruchelvam","year":"2000","unstructured":"Thiruchelvam M, Brockel BJ, Richfield EK, Baggs RB, Cory-Slechta DA (2000) Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson\u2019s disease? Brain Res 873:225\u2013234. https:\/\/doi.org\/10.1016\/S0006-8993(00)02496-3","journal-title":"Brain Res"},{"key":"1148_CR11","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol 15:1257\u20131272. https:\/\/doi.org\/10.1016\/S1474-4422(16)30230-7","journal-title":"Lancet Neurol"},{"key":"1148_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.lpm.2017.01.001","volume":"46","author":"A Delamarre","year":"2017","unstructured":"Delamarre A, Meissner WG (2017) Epidemiology, environmental risk factors and genetics of Parkinson\u2019s disease. Presse Med 46:175\u2013181. https:\/\/doi.org\/10.1016\/j.lpm.2017.01.001","journal-title":"Presse Med"},{"key":"1148_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/bmb\/ldl018","volume":"79-80","author":"FD Dick","year":"2006","unstructured":"Dick FD (2006) Parkinson\u2019s disease and pesticide exposures. Br Med Bull 79-80:219\u2013231. https:\/\/doi.org\/10.1093\/bmb\/ldl018","journal-title":"Br Med Bull"},{"key":"1148_CR14","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/mds.22032","volume":"23","author":"C Aguiar Pde","year":"2008","unstructured":"Aguiar Pde C, Lessa PS, Jr GC, Barsottini O, Fel\u00edcio AC, Borges V, Silva SM, Saba RA et al (2008) Genetic and environmental findings in early-onset Parkinson\u2019s disease Brazilian patients. Mov Disord 23:1228\u20131233. https:\/\/doi.org\/10.1002\/mds.22032","journal-title":"Mov Disord"},{"key":"1148_CR15","doi-asserted-by":"publisher","first-page":"7560","DOI":"10.1002\/anie.201400491","volume":"53","author":"W Paslawski","year":"2014","unstructured":"Paslawski W, Mysling S, Thomsen K, J\u00f8rgensen TJ, Otzen DE (2014) Co-existence of two different \u03b1-synuclein oligomers with different core structures determined by hydrogen\/deuterium exchange mass spectrometry. Angew Chem Int Ed Engl 53:7560\u20137563. https:\/\/doi.org\/10.1002\/anie.201400491","journal-title":"Angew Chem Int Ed Engl"},{"key":"1148_CR16","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/S1353-8020(13)70011-7","volume":"20","author":"M Spatola","year":"2014","unstructured":"Spatola M, Wider C (2014) Genetics of Parkinson\u2019s disease: the yield. Parkinsonism Relat Disord 20:S35\u2013S38. https:\/\/doi.org\/10.1016\/S1353-8020(13)70011-7","journal-title":"Parkinsonism Relat Disord"},{"key":"1148_CR17","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/j.1742-4658.2012.08516.x","volume":"279","author":"T Alberio","year":"2012","unstructured":"Alberio T, Lopiano L, Fasano M (2012) Cellular models to investigate biochemical pathways in Parkinson\u2019s disease. FEBS J 279:1146\u20131155. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08516.x","journal-title":"FEBS J"},{"key":"1148_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mcn.2014.08.002","volume":"62","author":"R Perfeito","year":"2014","unstructured":"Perfeito R, L\u00e1zaro DF, Outeiro TF, Rego AC (2014) Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells. Mol Cell Neurosci 62:51\u201359. https:\/\/doi.org\/10.1016\/j.mcn.2014.08.002","journal-title":"Mol Cell Neurosci"},{"key":"1148_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrn.2017.25","volume":"18","author":"S Przedborski","year":"2017","unstructured":"Przedborski S (2017) The two-century journey of Parkinson disease research. Nat Rev Neurosci 18:251\u2013259. https:\/\/doi.org\/10.1038\/nrn.2017.25","journal-title":"Nat Rev Neurosci"},{"key":"1148_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/mds.23795","volume":"27","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA (2012) Neuropathology of sporadic Parkinson\u2019s disease: evaluation and changes of concepts. Mov Disord 27:8\u201330. https:\/\/doi.org\/10.1002\/mds.23795","journal-title":"Mov Disord"},{"key":"1148_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrneurol.2016.200","volume":"13","author":"DH Ffytche","year":"2017","unstructured":"Ffytche DH, Creese B, Politis M, Chaudhuri KR, Weintraub D, Ballard C, Aarsland D (2017) The psychosis spectrum in Parkinson disease. Nat Rev Neurol 13:81\u201395. https:\/\/doi.org\/10.1038\/nrneurol.2016.200","journal-title":"Nat Rev Neurol"},{"key":"1148_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.parkreldis.2017.01.011","volume":"38","author":"RD Salazar","year":"2017","unstructured":"Salazar RD, Le AM, Neargarder S, Cronin-Golomb A (2017) The impact of motor symptoms on self-reported anxiety in Parkinson\u2019s disease. Parkinsonism Relat Disord 38:26\u201330. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.01.011","journal-title":"Parkinsonism Relat Disord"},{"key":"1148_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrn.2017.91","volume":"18","author":"A Schapira","year":"2017","unstructured":"Schapira A, Chaudhuri K, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18:509. https:\/\/doi.org\/10.1038\/nrn.2017.91","journal-title":"Nat Rev Neurosci"},{"key":"1148_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2047-9158-3-10","volume":"3","author":"F Pan-Montojo","year":"2014","unstructured":"Pan-Montojo F, Reichmann H (2014) Considerations on the role of environmental toxins in idiopathic Parkinson\u2019s disease pathophysiology. Transl Neurodegener 3:10. https:\/\/doi.org\/10.1186\/2047-9158-3-10","journal-title":"Transl Neurodegener"},{"key":"1148_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2016.07.005","volume":"147","author":"T Jiang","year":"2016","unstructured":"Jiang T, Sun Q, Chen S (2016) Oxidative stress: a major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson\u2019s disease and Alzheimer\u2019s disease. Prog Neurobiol 147:1\u201319. https:\/\/doi.org\/10.1016\/j.pneurobio.2016.07.005","journal-title":"Prog Neurobiol"},{"key":"1148_CR26","first-page":"169","volume":"34","author":"HJ Tritschler","year":"1994","unstructured":"Tritschler HJ, Packer L, Medori R (1994) Oxidative stress and mitochondrial dysfunction in neurodegeneration. Biochem Mol Biol Int 34:169\u2013181","journal-title":"Biochem Mol Biol Int"},{"key":"1148_CR27","first-page":"24","volume":"13","author":"P Jenner","year":"1998","unstructured":"Jenner P (1998) Oxidative mechanisms in nigral cell death in Parkinson\u2019s disease. Mov Disord 13:24\u201334","journal-title":"Mov Disord"},{"key":"1148_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s11064-007-9482-y","volume":"33","author":"IG Onyango","year":"2008","unstructured":"Onyango IG (2008) Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Neurochem Res 33:589\u2013597. https:\/\/doi.org\/10.1007\/s11064-007-9482-y","journal-title":"Neurochem Res"},{"key":"1148_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-42139-1_2","volume-title":"Mitochondrial mechanisms of degeneration and repair in Parkinson\u2019s disease","author":"S Delcambre","year":"2016","unstructured":"Delcambre S, Nonnenmacher Y, Hiller K (2016) Dopamine metabolism and reactive oxygen species production. In: Buhlman LM (ed) Mitochondrial mechanisms of degeneration and repair in Parkinson\u2019s disease. Springer International Publishing, Switzerland. https:\/\/doi.org\/10.1007\/978-3-319-42139-1_2"},{"key":"1148_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF03033289","volume":"1","author":"D Sulzer","year":"2000","unstructured":"Sulzer D, Zecca L (2000) Intraneuronal dopamine-quinone synthesis: a review. Neurotox Res 1:181\u2013195","journal-title":"Neurotox Res"},{"key":"1148_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"key":"1148_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/WOX.0b013e3182439613","volume":"5","author":"E Birben","year":"2012","unstructured":"Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O (2012) Oxidative stress and antioxidant defense. World Allergy Organ J 5:9\u201319. https:\/\/doi.org\/10.1097\/WOX.0b013e3182439613","journal-title":"World Allergy Organ J"},{"key":"1148_CR33","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1212\/WNL.0b013e318294b3c8","volume":"80","author":"G Pezzoli","year":"2013","unstructured":"Pezzoli G, Cereda E (2013) Exposure to pesticides or solvents and risk of Parkinson disease. Neurology 80:2035\u20132041. https:\/\/doi.org\/10.1212\/WNL.0b013e318294b3c8","journal-title":"Neurology"},{"key":"1148_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/jech-2015-205455","volume":"70","author":"A Elbaz","year":"2016","unstructured":"Elbaz A, Moisan F (2016) The scientific bases to consider Parkinson\u2019s disease an occupational disease in agriculture professionals exposed to pesticides in France. J Epidemiol Community Health 70:319\u2013321. https:\/\/doi.org\/10.1136\/jech-2015-205455","journal-title":"J Epidemiol Community Health"},{"key":"1148_CR35","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1002\/ana.410440712","volume":"44","author":"P Jenner","year":"1998","unstructured":"Jenner P, Olanow CW (1998) Understanding cell death in Parkinson\u2019s disease. Ann Neurol 44:S72\u2013S84","journal-title":"Ann Neurol"},{"key":"1148_CR36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10072-013-1571-x","volume":"35","author":"JC Nunes","year":"2014","unstructured":"Nunes JC, Costa Bergamaschi EN, Freitas FC, Diaz AP, Queiroz LP, Debona R, Prediger RD, Linhares MN et al (2014) Prevalence of headache in patients with Parkinson\u2019s disease and its association with the side of motor symptom onset. Neurol Sci 35:595\u2013600. https:\/\/doi.org\/10.1007\/s10072-013-1571-x","journal-title":"Neurol Sci"},{"key":"1148_CR37","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1289\/ehp.9951","volume":"115","author":"TM Edwards","year":"2007","unstructured":"Edwards TM, Myers JP (2007) Environmental exposures and gene regulation in disease etiology. Environ Health Perspect 115:1264\u20131270. https:\/\/doi.org\/10.1289\/ehp.9951","journal-title":"Environ Health Perspect"},{"key":"1148_CR38","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.1021\/ja01532a030","volume":"81","author":"S Senoh","year":"1959","unstructured":"Senoh S, Creveling CR, Udenfriend S, Witkop B (1959) Chemical, enzymatic and metabolic studies on the mechanisms of oxidation of dopamine. J Am Chem Soc 81:6236\u20136340","journal-title":"J Am Chem Soc"},{"key":"1148_CR39","doi-asserted-by":"publisher","first-page":"6222","DOI":"10.1021\/ja01532a028","volume":"81","author":"S Senoh","year":"1959","unstructured":"Senoh S, Witkop B (1959) Non-enzymtic conversions to dopamine to norepinephrine and trihydroxyhenetylamines. J Am Chem Soc 81:6222\u20136231","journal-title":"J Am Chem Soc"},{"key":"1148_CR40","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0022-3565(25)26555-7","volume":"140","author":"CC Porter","year":"1963","unstructured":"Porter CC, Totaro JA, Stone CA (1963) Effect of 6-hydroxydopamine and some other compounds on the concentration of norepinephrine in the hearts of mice. J Pharmacol Exp Ther 140:308\u2013316","journal-title":"J Pharmacol Exp Ther"},{"key":"1148_CR41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-3565(25)27139-7","volume":"150","author":"CC Porter","year":"1965","unstructured":"Porter CC, Totaro JA, Burcin A (1965) The relationship between radioactivity and norepinephrine concentrations in the brains and hearts of mice following administration of labeled methyldopa or 6-hydroxydopamine. J Pharmacol Exp Ther 150:17\u201322","journal-title":"J Pharmacol Exp Ther"},{"key":"1148_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","volume":"5","author":"U Ungerstedt","year":"1968","unstructured":"Ungerstedt U (1968) 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 5:107\u2013110. https:\/\/doi.org\/10.1016\/0014-2999(68)90164-7","journal-title":"Eur J Pharmacol"},{"key":"1148_CR43","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/bies.10067","volume":"24","author":"R Betarbet","year":"2002","unstructured":"Betarbet R, Sherer TB, Greenamyre JT (2002) Animal models of Parkinson\u2019s disease. Bioessays 24:308\u2013318. https:\/\/doi.org\/10.1002\/bies.10067","journal-title":"Bioessays"},{"key":"1148_CR44","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0006-8993(89)90597-0","volume":"494","author":"DA Perese","year":"1989","unstructured":"Perese DA, Ulman J, Viola J, Ewing SE, Bankiewicz KS (1989) A 6-hydroxydopamine-induced selective parkinsonian rat model. Brain Res 494:285\u2013293. https:\/\/doi.org\/10.1016\/0006-8993(89)90597-0","journal-title":"Brain Res"},{"key":"1148_CR45","first-page":"49","volume":"100","author":"JW Langston","year":"1984","unstructured":"Langston JW, Langston EB, Irwin I (1984) MPTP-induced parkinsonism in human and non-human primates\u2014clinical and experimental aspects. Acta Neurol Scand Suppl 100:49\u201354","journal-title":"Acta Neurol Scand Suppl"},{"key":"1148_CR46","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","volume":"77","author":"NA Tatton","year":"1997","unstructured":"Tatton NA, Kish SJ (1997) In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience 77:1037\u20131048. https:\/\/doi.org\/10.1016\/S0306-4522(96)00545-3","journal-title":"Neuroscience"},{"key":"1148_CR47","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","volume":"4","author":"V Jackson-Lewis","year":"1995","unstructured":"Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S (1995) Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 4:257\u2013269","journal-title":"Neurodegeneration"},{"key":"1148_CR48","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0022-3565(24)36409-2","volume":"280","author":"P Chan","year":"1997","unstructured":"Chan P, Di Monte DA, Langston JW, Janson AM (1997) (+)MK-801 does not prevent MPTP-induced loss of nigral neurons in mice. J Pharmacol Exp Ther 280:439\u2013446","journal-title":"J Pharmacol Exp Ther"},{"key":"1148_CR49","doi-asserted-by":"publisher","first-page":"8160","DOI":"10.1073\/pnas.84.22.8160","volume":"84","author":"JF Reinhard Jr","year":"1987","unstructured":"Reinhard JF Jr, Diliberto EJ Jr, Viveros OH, Daniels AJ (1987) Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells. Proc Natl Acad Sci U S A 84:8160\u20138164","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1148_CR50","doi-asserted-by":"publisher","first-page":"9074","DOI":"10.1073\/pnas.89.19.9074","volume":"89","author":"Y Liu","year":"1992","unstructured":"Liu Y, Roghani A, Edwards RH (1992) Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium. Proc Natl Acad Sci U S A 89:9074\u20139078","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1148_CR51","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0006-8993(02)03514-X","volume":"956","author":"GE Meredith","year":"2002","unstructured":"Meredith GE, Totterdell S, Petroske E, Santa Cruz K, Callison RC Jr, Lau YS (2002) Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson\u2019s disease. Brain Res 956:156\u2013165. https:\/\/doi.org\/10.1016\/S0006-8993(02)03514-X","journal-title":"Brain Res"},{"key":"1148_CR52","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1046\/j.1471-4159.2000.740721.x","volume":"74","author":"M Vila","year":"2000","unstructured":"Vila M, Vukosavic S, Jackson-Lewis V, Neystat M, Jakowec M, Przedborski S (2000) Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J Neurochem 74:721\u2013729. https:\/\/doi.org\/10.1046\/j.1471-4159.2000.740721.x","journal-title":"J Neurochem"},{"key":"1148_CR53","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.neuro.2012.05.011","volume":"33","author":"C Freire","year":"2012","unstructured":"Freire C, Koifman S (2012) Pesticide exposure and Parkinson\u2019s disease: epidemiological evidence of association. Neurotoxicology 33:947\u2013971. https:\/\/doi.org\/10.1016\/j.neuro.2012.05.011","journal-title":"Neurotoxicology"},{"key":"1148_CR54","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.vascn.2016.10.003","volume":"83","author":"C Nasuti","year":"2017","unstructured":"Nasuti C, Brunori G, Eusepi P, Marinelli L, Ciccocioppo R, Gabbianelli R (2017) Early life exposure to permethrin: a progressive animal model of Parkinson\u2019s disease. J Pharmacol Toxicol Methods 83:80\u201386. https:\/\/doi.org\/10.1016\/j.vascn.2016.10.003","journal-title":"J Pharmacol Toxicol Methods"},{"key":"1148_CR55","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/tox.21943","volume":"30","author":"S Bast\u00edas-Candia","year":"2015","unstructured":"Bast\u00edas-Candia S, Di Benedetto M, D\u2019Addario C, Candeletti S, Romualdi P (2015) Combined exposure to agriculture pesticides, paraquat and maneb, induces alterations in the N\/OFQ-NOPr and PDYN\/KOPr systems in rats: relevance to sporadic Parkinson\u2019s disease. Environ Toxicol 30:656\u2013663. https:\/\/doi.org\/10.1002\/tox.21943","journal-title":"Environ Toxicol"},{"key":"1148_CR56","doi-asserted-by":"publisher","first-page":"42026","DOI":"10.1074\/jbc.M508628200","volume":"280","author":"A Panov","year":"2005","unstructured":"Panov A, Dikalov S, Shalbuyeva N, Taylor G, Sherer T, Greenamyre JT (2005) Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication. J Biol Chem 280:42026\u201342035. https:\/\/doi.org\/10.1074\/jbc.M508628200","journal-title":"J Biol Chem"},{"key":"1148_CR57","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bbadis.2008.09.014","volume":"1792","author":"MK Borland","year":"2009","unstructured":"Borland MK, Mohanakumar KP, Rubinstein JD, Keeney PM, Xie J, Capaldi R, Dunham LD, Trimmer PA et al (2009) Relationships among molecular genetic and respiratory properties of Parkinson\u2019s disease cybrid cells show similarities to Parkinson\u2019s brain tissues. Biochim Biophys Acta 1792:68\u201374. https:\/\/doi.org\/10.1016\/j.bbadis.2008.09.014","journal-title":"Biochim Biophys Acta"},{"key":"1148_CR58","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1126\/science.70.1820.478-a","volume":"70","author":"EP Clark","year":"1929","unstructured":"Clark EP (1929) The occurrence of rotenone in the Peruvian fish poison \u201ccube\u201d. Science 70:478\u2013479","journal-title":"Science"},{"key":"1148_CR59","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0304-3940(85)90580-4","volume":"62","author":"RE Heikkila","year":"1985","unstructured":"Heikkila RE, Nicklas WJ, Vyas I, Duvoisin RC (1985) Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Neurosci Lett 62:389\u2013394. https:\/\/doi.org\/10.1016\/0304-3940(85)90580-4","journal-title":"Neurosci Lett"},{"key":"1148_CR60","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00441-004-0937-z","volume":"318","author":"VN Uversky","year":"2004","unstructured":"Uversky VN (2004) Neurotoxicant-induced animal models of Parkinson\u2019s disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration. Cell Tissue Res 318:225\u2013241. https:\/\/doi.org\/10.1007\/s00441-004-0937-z","journal-title":"Cell Tissue Res"},{"key":"1148_CR61","doi-asserted-by":"publisher","first-page":"14524","DOI":"10.1073\/pnas.172514599","volume":"99","author":"W Dauer","year":"2002","unstructured":"Dauer W, Kholodilov N, Vila M, Trillat AC, Goodchild R, Larsen KE, Staal R, Tieu K et al (2002) Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci U S A 99:14524\u201314529. https:\/\/doi.org\/10.1073\/pnas.172514599","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1148_CR62","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0006-8993(97)00008-5","volume":"753","author":"RJ Ferrante","year":"1997","unstructured":"Ferrante RJ, Schulz JB, Kowall NW, Beal MF (1997) Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra. Brain Res 753:157\u2013162. https:\/\/doi.org\/10.1016\/S0006-8993(97)00008-5","journal-title":"Brain Res"},{"key":"1148_CR63","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.pneurobio.2004.05.002","volume":"73","author":"O Bohlen und Halbach von","year":"2004","unstructured":"von Bohlen und Halbach O, Schober A, Krieglstein K (2004) Genes, proteins, and neurotoxins involved in Parkinson\u2019s disease. Prog Neurobiol 73:151\u2013177. https:\/\/doi.org\/10.1016\/j.pneurobio.2004.05.002","journal-title":"Prog Neurobiol"},{"key":"1148_CR64","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1046\/j.1471-4159.2000.0752611.x","volume":"75","author":"DJ Talpade","year":"2000","unstructured":"Talpade DJ, Greene JG, Higgins DS Jr, Greenamyre JT (2000) In vivo labeling of mitochondrial complex I (NADH:ubiquinone oxidoreductase) in rat brain using [(3)H]dihydrorotenone. J Neurochem 75:2611\u20132621. https:\/\/doi.org\/10.1046\/j.1471-4159.2000.0752611.x","journal-title":"J Neurochem"},{"key":"1148_CR65","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/ps.364","volume":"57","author":"F Schuler","year":"2001","unstructured":"Schuler F, Casida JE (2001) The insecticide target in the PSST subunit of complex I. Pest Manag Sci 57:932\u2013940. https:\/\/doi.org\/10.1002\/ps.364","journal-title":"Pest Manag Sci"},{"key":"1148_CR66","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","volume":"34","author":"JR Cannon","year":"2009","unstructured":"Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, Greenamyre JT (2009) A highly reproducible rotenone model of Parkinson\u2019s disease. Neurobiol Dis 34:279\u2013290. https:\/\/doi.org\/10.1016\/j.nbd.2009.01.016","journal-title":"Neurobiol Dis"},{"key":"1148_CR67","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuro.2014.12.002","volume":"46","author":"ME Johnson","year":"2015","unstructured":"Johnson ME, Bobrovskaya L (2015) An update on the rotenone models of Parkinson\u2019s disease: their ability to reproduce the features of clinical disease and model gene-environment interactions. Neurotoxicology 46:101\u2013116. https:\/\/doi.org\/10.1016\/j.neuro.2014.12.002","journal-title":"Neurotoxicology"},{"key":"1148_CR68","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1365-2559.1980.tb02911.x","volume":"4","author":"H Grant","year":"1980","unstructured":"Grant H, Lantos PL, Parkinson C (1980) Cerebral damage in paraquat poisoning. Histopathology 4:185\u2013195. https:\/\/doi.org\/10.1111\/j.1365-2559.1980.tb02911.x","journal-title":"Histopathology"},{"key":"1148_CR69","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/0024-3205(85)90185-7","volume":"37","author":"A Barbeau","year":"1985","unstructured":"Barbeau A, Dallaire L, Buu NT, Poirier J, Rucinska E (1985) Comparative behavioral, biochemical and pigmentary effects of MPTP, MPP+ and paraquat in Rana pipiens. Life Sci 37:1529\u20131538","journal-title":"Life Sci"},{"key":"1148_CR70","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.tips.2008.03.007","volume":"29","author":"JM Hatcher","year":"2008","unstructured":"Hatcher JM, Pennell KD, Miller GW (2008) Parkinson\u2019s disease and pesticides: a toxicological perspective. Trends Pharmacol Sci 29:322\u2013329. https:\/\/doi.org\/10.1016\/j.tips.2008.03.007","journal-title":"Trends Pharmacol Sci"},{"key":"1148_CR71","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1177\/096032719501400706","volume":"14","author":"JL Naylor","year":"1995","unstructured":"Naylor JL, Widdowson PS, Simpson MG, Farnworth M, Ellis MK, Lock EA (1995) Further evidence that the blood\/brain barrier impedes paraquat entry into the brain. Hum Exp Toxicol 14:587\u2013594. https:\/\/doi.org\/10.1177\/096032719501400706","journal-title":"Hum Exp Toxicol"},{"key":"1148_CR72","doi-asserted-by":"publisher","first-page":"198","DOI":"10.4103\/2230-8229.122023","volume":"20","author":"K Raghu","year":"2013","unstructured":"Raghu K, Mahesh V, Sasidhar P, Reddy PR, Venkataramaniah V, Agrawal A (2013) Paraquat poisoning: a case report and review of literature. J Family Community Med 20:198\u2013200. https:\/\/doi.org\/10.4103\/2230-8229.122023","journal-title":"J Family Community Med"},{"key":"1148_CR73","first-page":"383","volume":"50","author":"C Sittipunt","year":"2005","unstructured":"Sittipunt C (2005) Paraquat poisoning. Respir Care 50:383\u2013385","journal-title":"Respir Care"},{"key":"1148_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0006-8993(98)01192-5","volume":"823","author":"AI Brooks","year":"1999","unstructured":"Brooks AI, Chadwick CA, Gelbard HA, Cory-Slechta DA, Federoff HJ (1999) Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res 823:1\u201310. https:\/\/doi.org\/10.1016\/S0006-8993(98)01192-5","journal-title":"Brain Res"},{"key":"1148_CR75","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1006\/nbdi.2002.0507","volume":"10","author":"AL McCormack","year":"2002","unstructured":"McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Langston JW, Cory-Slechta DA, Di Monte DA (2002) Environmental risk factors and Parkinson\u2019s disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis 10:119\u2013127. https:\/\/doi.org\/10.1006\/nbdi.2002.0507","journal-title":"Neurobiol Dis"},{"key":"1148_CR76","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1074\/jbc.C100560200","volume":"277","author":"AB Manning-Bog","year":"2002","unstructured":"Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA (2002) The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem 277:1641\u20131644. https:\/\/doi.org\/10.1074\/jbc.C100560200","journal-title":"J Biol Chem"},{"key":"1148_CR77","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/07391102.2003.10506918","volume":"21","author":"VN Uversky","year":"2003","unstructured":"Uversky VN (2003) A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders. J Biomol Struct Dyn 21:211\u2013234","journal-title":"J Biomol Struct Dyn"},{"key":"1148_CR78","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.etap.2015.09.019","volume":"40","author":"FF Caputi","year":"2015","unstructured":"Caputi FF, Carretta D, Lattanzio F, Palmisano M, Candeletti S, Romualdi P (2015) Proteasome subunit and opioid receptor gene expression down-regulation induced by paraquat and maneb in human neuroblastoma SH-SY5Y cells. Environ Toxicol Pharmacol 40:895\u2013900. https:\/\/doi.org\/10.1016\/j.etap.2015.09.019","journal-title":"Environ Toxicol Pharmacol"},{"key":"1148_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0773.1998.tb01434.x","volume":"83","author":"MT Corasaniti","year":"1998","unstructured":"Corasaniti MT, Strongoli MC, Rotiroti D, Bagetta G, Nistic\u00f2 G (1998) Paraquat: a useful tool for the in vivo study of mechanisms of neuronal cell death. Pharmacol Toxicol 83:1\u20137","journal-title":"Pharmacol Toxicol"},{"key":"1148_CR80","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0006-8993(01)02577-X","volume":"906","author":"K Shimizu","year":"2001","unstructured":"Shimizu K, Ohtaki K, Matsubara K, Aoyama K, Uezono T, Saito O, Suno M, Ogawa K et al (2001) Carrier-mediated processes in blood\u2013brain barrier penetration and neural uptake of paraquat. Brain Res 906:135\u2013142. https:\/\/doi.org\/10.1016\/S0006-8993(01)02577-X","journal-title":"Brain Res"},{"key":"1148_CR81","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0006-8993(95)01419-5","volume":"712","author":"BK Edmonds","year":"1996","unstructured":"Edmonds BK, Edwards GL (1996) The area postrema is involved in paraquat-induced conditioned aversion behavior and neuroendocrine activation of the hypothalamic-pituitary-adrenal axis. Brain Res 712:127\u2013133. https:\/\/doi.org\/10.1016\/0006-8993(95)01419-5","journal-title":"Brain Res"},{"key":"1148_CR82","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1289\/ehp.9932","volume":"115","author":"K Prasad","year":"2007","unstructured":"Prasad K, Winnik B, Thiruchelvam MJ, Buckley B, Mirochnitchenko O, Richfield EK (2007) Prolonged toxicokinetics and toxicodynamics of paraquat in mouse brain. Environ Health Perspect 115:1448\u20131453. https:\/\/doi.org\/10.1289\/ehp.9932","journal-title":"Environ Health Perspect"},{"key":"1148_CR83","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0006-8993(03)02750-1","volume":"976","author":"K Shimizu","year":"2003","unstructured":"Shimizu K, Matsubara K, Ohtaki K, Fujimaru S, Saito O, Shiono H (2003) Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats. Brain Res 976:243\u2013252. https:\/\/doi.org\/10.1016\/S0006-8993(03)02750-1","journal-title":"Brain Res"},{"key":"1148_CR84","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/toxsci\/kfi304","volume":"88","author":"JR Richardson","year":"2005","unstructured":"Richardson JR, Quan Y, Sherer TB, Greenamyre JT, Miller GW (2005) Paraquat neurotoxicity is distinct from that of MPTP and rotenone. Toxicol Sci 88:193\u2013201. https:\/\/doi.org\/10.1093\/toxsci\/kfi304","journal-title":"Toxicol Sci"},{"key":"1148_CR85","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/jat.2926","volume":"34","author":"V Vilas-Boas","year":"2014","unstructured":"Vilas-Boas V, Silva R, Guedes-de-Pinho P, Carvalho F, Bastos ML, Remi\u00e3o F (2014) RBE4 cells are highly resistant to paraquat-induced cytotoxicity: studies on uptake and efflux mechanisms. J Appl Toxicol 34:1023\u20131030. https:\/\/doi.org\/10.1002\/jat.2926","journal-title":"J Appl Toxicol"},{"key":"1148_CR86","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.toxlet.2009.03.026","volume":"188","author":"MJ Kang","year":"2009","unstructured":"Kang MJ, Gil SJ, Koh HC (2009) Paraquat induces alternation of the dopamine catabolic pathways and glutathione levels in the substantia nigra of mice. Toxicol Lett 188:148\u2013152. https:\/\/doi.org\/10.1016\/j.toxlet.2009.03.026","journal-title":"Toxicol Lett"},{"key":"1148_CR87","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1089\/ARS.2009.2459","volume":"11","author":"AC Crist\u00f3v\u00e3o","year":"2009","unstructured":"Crist\u00f3v\u00e3o AC, Choi DH, Baltazar G, Beal MF, Kim YS (2009) The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death. Antioxid Redox Signal 11:2105\u20132118. https:\/\/doi.org\/10.1089\/ARS.2009.2459","journal-title":"Antioxid Redox Signal"},{"key":"1148_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tox.2017.02.009","volume":"380","author":"L Hou","year":"2017","unstructured":"Hou L, Zhang C, Wang K, Liu X, Wang H, Che Y, Sun F, Zhou X et al (2017) Paraquat and maneb co-exposure induces noradrenergic locus coeruleus neurodegeneration through NADPH oxidase-mediated microglial activation. Toxicology 380:1\u201310. https:\/\/doi.org\/10.1016\/j.tox.2017.02.009","journal-title":"Toxicology"},{"key":"1148_CR89","doi-asserted-by":"publisher","first-page":"32626","DOI":"10.1074\/jbc.M404596200","volume":"279","author":"J Peng","year":"2004","unstructured":"Peng J, Mao XO, Stevenson FF, Hsu M, Andersen JK (2004) The herbicide paraquat induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway. J Biol Chem 279:32626\u201332632. https:\/\/doi.org\/10.1074\/jbc.M404596200","journal-title":"J Biol Chem"},{"key":"1148_CR90","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2202-10-88","volume":"10","author":"M Somayajulu-Ni\u0163u","year":"2009","unstructured":"Somayajulu-Ni\u0163u M, Sandhu JK, Cohen J, Sikorska M, Sridhar TS, Matei A, Borowy-Borowski H, Pandey S (2009) Paraquat induces oxidative stress, neuronal loss in substantia nigra region and parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q10. BMC Neurosci 10:88. https:\/\/doi.org\/10.1186\/1471-2202-10-88","journal-title":"BMC Neurosci"},{"key":"1148_CR91","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1080\/15287390500226987","volume":"68","author":"W Yang","year":"2005","unstructured":"Yang W, Tiffany-Castiglioni E (2005) The bipyridyl herbicide paraquat produces oxidative stress-mediated toxicity in human neuroblastoma SH-SY5Y cells: relevance to the dopaminergic pathogenesis. J Toxicol Environ Health A 68:1939\u20131961","journal-title":"J Toxicol Environ Health A"},{"key":"1148_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/toxsci\/kfm223","volume":"100","author":"GW Miller","year":"2007","unstructured":"Miller GW (2007) Paraquat: the red herring of Parkinson\u2019s disease research. Toxicol Sci 100:1\u20132. https:\/\/doi.org\/10.1093\/toxsci\/kfm223","journal-title":"Toxicol Sci"},{"key":"1148_CR93","doi-asserted-by":"publisher","first-page":"29194","DOI":"10.1074\/jbc.M500984200","volume":"280","author":"J Peng","year":"2005","unstructured":"Peng J, Stevenson FF, Doctrow SR, Andersen JK (2005) Superoxide dismutase\/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: implications for Parkinson disease. J Biol Chem 280:29194\u201329198. https:\/\/doi.org\/10.1074\/jbc.M500984200","journal-title":"J Biol Chem"},{"key":"1148_CR94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098886","volume":"9","author":"AK Shukla","year":"2014","unstructured":"Shukla AK, Pragya P, Chaouhan HS, Tiwari AK, Patel DK, Abdin MZ, Chowdhuri DK (2014) Heat shock protein-70 (Hsp-70) suppresses paraquat-induced neurodegeneration by inhibiting JNK and caspase-3 activation in Drosophila model of Parkinson\u2019s disease. PLoS One 9:e98886. https:\/\/doi.org\/10.1371\/journal.pone.0098886","journal-title":"PLoS One"},{"key":"1148_CR95","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrn2755","volume":"11","author":"NC Inestrosa","year":"2010","unstructured":"Inestrosa NC, Arenas E (2010) Emerging roles of Wnts in the adult nervous system. Nat Rev Neurosci 11:77\u201386. https:\/\/doi.org\/10.1038\/nrn2755","journal-title":"Nat Rev Neurosci"},{"key":"1148_CR96","first-page":"806","volume":"33","author":"M Yan","year":"2015","unstructured":"Yan M, Wang X, Zhao L, Chang X, Zhou Z (2015) The effect of Wnt signaling pathway on paraquat induced PC12 cells damage. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 33:806\u2013811","journal-title":"Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi"},{"key":"1148_CR97","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1089\/ars.2016.6711","volume":"27","author":"M Hichor","year":"2017","unstructured":"Hichor M, Sampathkumar NK, Montanaro J, Borderie D, Petit PX, Gorgievski V, Tzavara ET, Eid AA et al (2017) Paraquat induces peripheral myelin disruption and locomotor defects: crosstalk with LXR and Wnt pathways. Antioxid Redox Signal 27:168\u2013183. https:\/\/doi.org\/10.1089\/ars.2016.6711","journal-title":"Antioxid Redox Signal"},{"key":"1148_CR98","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fncel.2015.00209","volume":"9","author":"B Alural","year":"2015","unstructured":"Alural B, Ozerdem A, Allmer J, Genc K, Genc S (2015) Lithium protects against paraquat neurotoxicity by NRF2 activation and miR-34a inhibition in SH-SY5Y cells. Front Cell Neurosci 9:209. https:\/\/doi.org\/10.3389\/fncel.2015.00209","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"1148_CR99","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11064-010-0368-z","volume":"36","author":"Y Yong","year":"2011","unstructured":"Yong Y, Ding H, Fan Z, Luo J, Ke ZJ (2011) Lithium fails to protect dopaminergic neurons in the 6-OHDA model of Parkinson\u2019s disease. Neurochem Res 36(3):367\u2013374. https:\/\/doi.org\/10.1007\/s11064-010-0368-z","journal-title":"Neurochem Res"},{"key":"1148_CR100","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neuro.2017.04.010","volume":"60","author":"J Sandstr\u00f6m","year":"2017","unstructured":"Sandstr\u00f6m J, Broyer A, Zoia D, Schilt C, Greggio C, Fournier M, Do KQ, Monnet-Tschudi F (2017) Potential mechanisms of development-dependent adverse effects of the herbicide paraquat in 3D rat brain cell cultures. Neurotoxicology 60:116\u2013124. https:\/\/doi.org\/10.1016\/j.neuro.2017.04.010","journal-title":"Neurotoxicology"},{"key":"1148_CR101","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.mito.2007.02.007","volume":"7","author":"HM Cochem\u00e9","year":"2007","unstructured":"Cochem\u00e9 HM, Kelso GF, James AM, Ross MF, Trnka J, Mahendiran T, Asin-Cayuela J, Blaikie FH et al (2007) Mitochondrial targeting of quinones: therapeutic implications. Mitochondrion 7:S94\u2013S102. https:\/\/doi.org\/10.1016\/j.mito.2007.02.007","journal-title":"Mitochondrion"},{"key":"1148_CR102","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1074\/jbc.M708597200","volume":"283","author":"HM Cochem\u00e9","year":"2008","unstructured":"Cochem\u00e9 HM, Murphy MP (2008) Complex I is the major site of mitochondrial superoxide production by paraquat. J Biol Chem 283:1786\u20131798. https:\/\/doi.org\/10.1074\/jbc.M708597200","journal-title":"J Biol Chem"},{"key":"1148_CR103","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/0160-9327(71)90039-1","volume":"30","author":"AD Dodge","year":"1971","unstructured":"Dodge AD (1971) The mode of action of the bipyridylium herbicides, paraquat and diquat. Endeavour 30:130\u2013135","journal-title":"Endeavour"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1148-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-1148-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1148-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T23:19:46Z","timestamp":1751671186000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-1148-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,3]]},"references-count":103,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1148"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-1148-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,3]]},"assertion":[{"value":"23 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}